These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 16760461)

  • 1. The standardization of expiration-date labels.
    Itzchaki S; Lazar E; Deland E
    N Engl J Med; 2006 Jun; 354(23):2515-6. PubMed ID: 16760461
    [No Abstract]   [Full Text] [Related]  

  • 2. Should expiration dates be required on patients' prescription labels?
    Hadeler F
    Am Pharm; 1986 Aug; NS26(8):30-5. PubMed ID: 3776829
    [No Abstract]   [Full Text] [Related]  

  • 3. Pediatric priorities: legislative and regulatory initiatives to expand research on the use of medicines in pediatric patients.
    Labson MS
    J Health Care Law Policy; 2002; 6(1):34-72. PubMed ID: 15017951
    [No Abstract]   [Full Text] [Related]  

  • 4. The federal preemption debate in pharmaceutical labeling product liability actions.
    Gross JM; Curry JA
    Tort Trial Insur Pract Law J; 2007; 43(1):35-70. PubMed ID: 18354866
    [No Abstract]   [Full Text] [Related]  

  • 5. Off-label or off-limits?
    Ratner M; Gura T
    Nat Biotechnol; 2008 Aug; 26(8):867-75. PubMed ID: 18688236
    [No Abstract]   [Full Text] [Related]  

  • 6. The concept of drug expiration dating.
    Wollish EG
    Bull Parenter Drug Assoc; 1969; 23(1):48-52. PubMed ID: 5765721
    [No Abstract]   [Full Text] [Related]  

  • 7. Drug product expiration dates: practice implications.
    MacDonnell CP; Campbell NA
    Med Health R I; 2002 Apr; 85(4):136-7. PubMed ID: 11989404
    [No Abstract]   [Full Text] [Related]  

  • 8. Expiration dating of drugs under way.
    Cohn JP
    Am Pharm; 1980 Mar; NS20(3):10. PubMed ID: 7369125
    [No Abstract]   [Full Text] [Related]  

  • 9. To inform or persuade? Direct-to-consumer advertising of prescription drugs.
    Berndt ER
    N Engl J Med; 2005 Jan; 352(4):325-8. PubMed ID: 15673797
    [No Abstract]   [Full Text] [Related]  

  • 10. Educating patients about their medications: the potential and limitations of written drug information.
    Shrank WH; Avorn J
    Health Aff (Millwood); 2007; 26(3):731-40. PubMed ID: 17485751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Food and Drug Administration's regulation of drug labeling, advertising, and promotion: looking back and looking ahead.
    Hayes TA
    Clin Pharmacol Ther; 1998 Jun; 63(6):607-16. PubMed ID: 9663174
    [No Abstract]   [Full Text] [Related]  

  • 12. Regulating off-label drug use--rethinking the role of the FDA.
    Stafford RS
    N Engl J Med; 2008 Apr; 358(14):1427-9. PubMed ID: 18385495
    [No Abstract]   [Full Text] [Related]  

  • 13. Recommendations for the labeling of large volume parenterals. National Coordinating Committee on Large Volume Parenterals.
    Am J Hosp Pharm; 1978 Jan; 35(1):49-51. PubMed ID: 623118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fourteen fallacies about patient package inserts.
    Goyan J
    West J Med; 1981 May; 134(5):463-8. PubMed ID: 7257361
    [No Abstract]   [Full Text] [Related]  

  • 15. Presumption of innocence: FDA's authority to regulate the specifics of prescription drug labeling and the preemption debate.
    Dorfman HL; Quinn VM; Brophy EA
    Food Drug Law J; 2006; 61(4):585-622. PubMed ID: 17180765
    [No Abstract]   [Full Text] [Related]  

  • 16. Increasing the odds of patient compliance through prescription warning labels.
    Ferguson JM; Discenza R; Miller JA
    J Health Care Mark; 1987 Mar; 7(1):37-46. PubMed ID: 10281382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Highlights and a hidden hazard--the FDA's new labeling regulations.
    Avorn J; Shrank W
    N Engl J Med; 2006 Jun; 354(23):2409-11. PubMed ID: 16760439
    [No Abstract]   [Full Text] [Related]  

  • 18. Determining the date of manufacture of drug products from lot numbers.
    Feldman MJ; Souney PF; Kaul AF
    Am J Hosp Pharm; 1979 Nov; 36(11):1545-7. PubMed ID: 517544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-review deadlines and safety problems.
    Nardinelli C; Lanthier M; Temple R
    N Engl J Med; 2008 Jul; 359(1):95-6; author reply 96-8. PubMed ID: 18596282
    [No Abstract]   [Full Text] [Related]  

  • 20. Informing patients about drugs: a wrong way and a right way.
    Woodson DW
    Med World News; 1979 Jun; 20(13):6. PubMed ID: 10242286
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.